missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Novus Biologicals™ CD200/OX2 Antibody (samalizumab) - IgG2SA, Novus Biologicals™
  7. 30048026

Novus Biologicals™ CD200/OX2 Antibody (samalizumab) - IgG2SA, Novus Biologicals™

Human Monoclonal Antibody

Brand:  Novus Biologicals™ NBP3-28596-100ug

 View more versions of this product

Product Code. 30048026

  • € 326.00 / 100µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CD200/OX2 Monoclonal antibody specifically detects CD200/OX2 in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD200/OX2
Monoclonal
Unconjugated
P41217
Human
Protein A purified
RUO
Primary
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Store at -20°C in powder form. Store at -80°C once reconstituted.
IgG2
Flow Cytometry, ELISA, Functional Assay
samalizumab
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
antigen identified by monoclonal MRC OX-2, CD200 antigenMOX1, CD200 molecule, MOX2MRC, MRC OX-2 antigen, OX-2, OX-2 membrane glycoprotein
CD200
100 μg
Immunology
4345
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.